title: Contributions of ocular surface components to matrix-metalloproteinases (MMP)-2 and MMP-9 in feline tears following corneal epithelial wounding.
abstract: OBJECTIVE
  This study investigated ocular surface components that contribute to matrix-metalloproteinase (MMP)-2 and MMP-9 found in tears following corneal epithelial wounding.
  
  
  METHODS
  Laboratory short-haired cats underwent corneal epithelial debridement in one randomly chosen eye (n = 18). Eye-flush tears were collected at baseline and during various healing stages. Procedural control eyes (identical experimental protocol as wounded eyes except for wounding, n = 5) served as controls for tear analysis. MMP activity was analyzed in tears using gelatin zymography. MMP staining patterns were evaluated in ocular tissues using immunohistochemistry and used to determine MMP expression sites responsible for tear-derived MMPs.
  
  
  RESULTS
  The proMMP-2 and proMMP-9 activity in tears was highest in wounded and procedural control eyes during epithelial migration (8 to 36 hours post-wounding). Wounded eyes showed significantly higher proMMP-9 in tears only during and after epithelial restratification (day 3 to 4 and day 7 to 28 post-wounding, respectively) as compared to procedural controls (p<0.05). Tears from wounded and procedural control eyes showed no statistical differences for pro-MMP-2 and MMP-9 (p>0.05). Immunohistochemistry showed increased MMP-2 and MMP-9 expression in the cornea during epithelial migration and wound closure. The conjunctival epithelium exhibited highest levels of both MMPs during wound closure, while MMP-9 expression was reduced in conjunctival goblet cells during corneal epithelial migration followed by complete absence of the cells during wound closure. The immunostaining for both MMPs was elevated in the lacrimal gland during corneal healing, with little/no change in the meibomian glands. Conjunctival-associated lymphoid tissue (CALT) showed weak MMP-2 and intense MMP-9 staining.
  
  
  CONCLUSIONS
  Following wounding, migrating corneal epithelium contributed little to the observed MMP levels in tears. The major sources assessed in the present study for tear-derived MMP-2 and MMP-9 following corneal wounding are the lacrimal gland and CALT. Other sources included stromal keratocytes and conjunctiva with goblet cells.
authors: Vision CRC, Sydney, Australia ; School of Optometry and Vision Science, University of New South Wales, Sydney, Australia.
authors: Andrea
authors: A
authors: Petznick
authors: Michele C
authors: MC
authors: Madigan
authors: Qian
authors: Q
authors: Garrett
authors: Deborah F
authors: DF
authors: Sweeney
authors: Margaret D M
authors: MD
authors: Evans
mesh_terms: D000818:Animals; D002415:Cats; D002465:Cell Movement; D003228:Conjunctiva / Q000201:enzymology / Q000473:pathology; D004792:Enzyme Precursors / Q000378:metabolism*; D004847:Epithelial Cells / Q000201:enzymology; D019573:Epithelium, Corneal / Q000201:enzymology / Q000473:pathology*; D005260:Female; D007765:Lacrimal Apparatus / Q000201:enzymology; D008221:Lymphoid Tissue / Q000201:enzymology; D008297:Male; D020778:Matrix Metalloproteinase 2 / Q000378:metabolism*; D020780:Matrix Metalloproteinase 9 / Q000378:metabolism*; D009928:Organ Specificity; D013666:Tears / Q000201:enzymology*; D014945:Wound Healing
chemical_list: D004792:Enzyme Precursors; D020778:Matrix Metalloproteinase 2; D020780:Matrix Metalloproteinase 9
references: Exp Eye Res. 2003 Jun;76(6):685-94
references: 12742351
references: Vet Ophthalmol. 2007 Jul-Aug;10(4):199-206
references: 17565550
references: Acta Ophthalmol. 2011 Feb;89(1):e75-81
references: 21272282
references: Invest Ophthalmol Vis Sci. 2004 Dec;45(12):4293-301
references: 15557435
references: Cancer Genomics Proteomics. 2009 Mar-Apr;6(2):75-83
references: 19451091
references: Coll Antropol. 2008 Oct;32 Suppl 2:15-9
references: 19138000
references: J Cell Sci. 2011 Aug 1;124(Pt 15):2666-75
references: 21750188
references: Prog Retin Eye Res. 2012 Nov;31(6):527-50
references: 22732126
references: Eye Contact Lens. 2004 Oct;30(4):189-93; discussion 205-6
references: 15499246
references: Invest Ophthalmol. 1975 Sep;14(9):648-61
references: 1158632
references: Semin Cell Dev Biol. 2008 Feb;19(1):34-41
references: 17707664
references: Ophthalmology. 1982 Jun;89(6):687-99
references: 6750492
references: Vet Ophthalmol. 2011 Nov;14(6):365-77
references: 22050735
references: J Refract Surg. 2000 Jan-Feb;16(1):32-9
references: 10693617
references: Mol Vis. 2008 Mar 17;14:542-9
references: 18385789
references: Curr Eye Res. 2010 Feb;35(2):165-75
references: 20136427
references: J Proteome Res. 2009 Nov;8(11):4889-905
references: 19705875
references: Br J Ophthalmol. 2008 Jun;92(6):856-9
references: 18460541
references: Biomaterials. 2011 Dec;32(34):8870-9
references: 21899881
references: Dev Biol. 1991 Oct;147(2):425-39
references: 1655541
references: J Proteome Res. 2004 May-Jun;3(3):410-6
references: 15253421
references: Curr Eye Res. 1998 Feb;17(2):174-82
references: 9523096
references: Pharmacol Res. 2011 Dec;64(6):614-23
references: 21843641
references: Toxicol Mech Methods. 2011 Jan;21(1):6-12
references: 21058936
references: Br J Ophthalmol. 2011 Jun;95(6):848-52
references: 21030416
references: JAMA Ophthalmol. 2013 Jan;131(1):24-8
references: 23307206
references: J Cell Physiol. 2009 Nov;221(2):402-11
references: 19626678
references: J Morphol. 2002 Dec;254(3):247-58
references: 12386895
references: Invest Ophthalmol Vis Sci. 2007 Oct;48(10):4390; 4391-8
references: 17898256
references: Eye (Lond). 2012 Aug;26(8):1138-44
references: 22766540
references: Cornea. 2013 Feb;32(2):211-6
references: 22673852
references: Proteomics. 2007 Sep;7(17):3194-206
references: 17676663
references: J Cataract Refract Surg. 2007 Jun;33(6):1051-64
references: 17531702
references: Cornea. 2007 Dec;26(10):1213-9
references: 18043179
references: Circ Res. 2003 May 2;92(8):827-39
references: 12730128
references: Invest Ophthalmol Vis Sci. 1990 Aug;31(8):1533-41
references: 2387684
references: PLoS One. 2011 Jan 13;6(1):e15781
references: 21249198
references: J Am Vet Med Assoc. 1974 Jul 15;165(2):172-4
references: 4837826
references: Curr Eye Res. 2010 Sep;35(9):771-7
references: 20795858
references: Adv Exp Med Biol. 1998;438:643-51
references: 9634949
references: Vet Ophthalmol. 2004 Nov-Dec;7(6):397-405
references: 15511281
references: Cont Lens Anterior Eye. 2008 Feb;31(1):29-37
references: 17913568
references: Vet Ophthalmol. 2012 May;15(3):164-71
references: 22050623
references: Invest Ophthalmol Vis Sci. 2010 Feb;51(2):1008-15
references: 19850837
references: Graefes Arch Clin Exp Ophthalmol. 2013 Mar;251(3):741-9
references: 23254483
references: Surv Ophthalmol. 1981 Sep-Oct;26(2):84-96
references: 7034254
references: Exp Eye Res. 2003 Dec;77(6):653-64
references: 14609553
references: Int J Cancer. 1996 Jan 3;65(1):57-62
references: 8543396
references: Br J Ophthalmol. 1999 Dec;83(12):1376-83
references: 10574817